Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease

被引:27
|
作者
Sukhu, K [1 ]
Poovalingam, V
Mahomed, R
Giangrande, PLF
机构
[1] Churchill Hosp, Oxford Haemophilia Ctr, Oxford OX3 7LJ, England
[2] Churchill Hosp, Thrombosis Unit, Oxford OX3 7LJ, England
[3] King Edward VIII Hosp, Dept Haematol, Nelson R Mandela Sch Med, Durban, South Africa
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2003年 / 25卷 / 04期
关键词
von Willebrand factor : Ag; race; ethnic variation; normal range; von Willebrand disease;
D O I
10.1046/j.1365-2257.2003.00523.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The amount and function of von Willebrand factor (VWF), measured against a panel of laboratory tests, is the normal basis for the diagnosis of von Willebrand's disease (VWD). The normal range for each test is usually obtained by assaying samples from a cross section of the local population or from a manufacturer's kit insert. While collecting normal controls for another study, population from Durban in South Africa, with its distinct ethnic mix of Africans, Indians and Caucasians were also studied. Previously, Indians from their subcontinent have not been looked at separately and compared with Africans and Caucasians. It is confirmed in a previous study (Miller, Dilley, Richardson, Craig, Evatt. (2001) American Journal of Hematology 67, 125) that African Americans had significantly higher VWF:Ag and FVIII levels when compared with Caucasians. In addition, it was found that there was a significant difference in VWF:Ag levels between Indians and Africans, and between Caucasians and Africans, whereas no significant difference between Indians and Caucasians. Africans, Indians and Caucasians with blood group O showed significantly lower VWF:Ag and FVIII than the other ABO blood groups. Normal ranges of VWF for different blood groups are well established and this information should be utilized while considering a diagnosis of VWD. It is proposed here that the influence of racial origin should also be considered in the clinical and laboratory evaluation of VWD.
引用
收藏
页码:247 / 249
页数:3
相关论文
共 50 条
  • [41] Optimizing therapy with factor VIII von Willebrand factor concentrates in von Willebrand disease
    Federici, AB
    Mannucci, PM
    [J]. HAEMOPHILIA, 1998, 4 : 7 - 10
  • [42] Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A
    Stokol, T
    Trepanier, L
    Parry, BW
    Finnin, BC
    [J]. RESEARCH IN VETERINARY SCIENCE, 1997, 63 (01) : 23 - 27
  • [43] VON WILLEBRAND FACTOR LEVELS AND VARIATIONS IN THE VON WILLEBRAND FACTOR GENE INDEPENDENTLY INFLUENCE LIVER STIFFNESS: THE ROTTERDAM STUDY
    Plompen, E. P. C.
    Schouten, J. N. L.
    de Maat, M. P. M.
    Hansen, B. E.
    Hofman, A.
    Uitterlinden, A. G.
    Stricker, B. H. C.
    Leebeek, F. W. G.
    Janssen, H. L. A.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S243 - S243
  • [44] von Willebrand factor antigen levels in Behcet disease
    Beyan, E
    Sadikoglu, B
    Ertugrul, E
    Beyan, C
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (01) : 70 - 72
  • [45] Pharmacokinetics of von Willebrand factor (human) in patients with von Willebrand disease (vWD)
    Menache, D
    Aronson, DL
    Kennedy, D
    Montgomery, RR
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P2097 - P2097
  • [46] Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
    Casonato, Alessandra
    Cattini, Maria Grazia
    Daidone, Viviana
    Pontara, Elena
    Bertomoro, Antonella
    Prandoni, Paolo
    [J]. PLOS ONE, 2016, 11 (08):
  • [47] The Relationship Between von Willebrand Factor Gene and von Willebrand Factor Antigen Levels in Dogs
    Aslan, Oznur
    Arslan, Korhan
    Keles, Ihsan
    Akyuz, Bilal
    Ulusan, Mehmet
    Ilgar, Esma Gamze
    Akcay, Aytac
    [J]. KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2016, 22 (04) : 585 - 590
  • [48] Von Willebrand Factor Modifiers and their effect on Subjects with and without von Willebrand Disease
    Depka, Mariovon
    Detering, Carsten
    Fursa, Alina
    Martensen, Hauke
    Wermes, Cornelia
    [J]. HAEMOPHILIA, 2014, 20 : 115 - 115
  • [49] Evaluation of an Automated von Willebrand Factor Activity Assay in von Willebrand Disease
    Trossaert, Marc
    Ternisien, Catherine
    Lefrancois, Armelle
    Llopis, Laura
    Goudemand, Jenny
    Sigaud, Marianne
    Fouassier, Marc
    Caron, Claudine
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (06) : E25 - E29
  • [50] Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    [J]. HAEMOPHILIA, 1998, 4 : 53 - 62